Literature DB >> 22311592

Pulmonary veno-occlusive disease: a misnomer?

Cindy R Miller1.   

Abstract

Pulmonary veno-occlusive disease (PVOD) is a rare entity with non-specific signs and symptoms and is nearly always associated with a dismal prognosis. This review will first consider pulmonary hypertension in general and then will focus on PVOD specifically with particular attention to the pathophysiology of the disease. Classically PVOD is described as a disease primarily involving obstructed venules, with the arterial side of the circulation involved to a lesser degree. This article discusses the demographics of affected individuals; the ways in which an accurate diagnosis can be made, including imaging features; predisposing diseases and associated disorders; and potential treatment.

Entities:  

Mesh:

Year:  2012        PMID: 22311592     DOI: 10.1007/s00247-012-2350-1

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  31 in total

Review 1.  Pulmonary veno-occlusive disease.

Authors:  J Mandel; E J Mark; C A Hales
Journal:  Am J Respir Crit Care Med       Date:  2000-11       Impact factor: 21.405

2.  Pulmonary hypertension associated with pulmonary occlusive vasculopathy after allogeneic bone marrow transplantation.

Authors:  M Seguchi; N Hirabayashi; Y Fujii; Y Azuno; N Fujita; K Takeda; Y Sato; M Nishimura; K Yamada; Y Oka
Journal:  Transplantation       Date:  2000-01-15       Impact factor: 4.939

Review 3.  Pulmonary arterial hypertension.

Authors:  Harrison W Farber; Joseph Loscalzo
Journal:  N Engl J Med       Date:  2004-10-14       Impact factor: 91.245

4.  Pulmonary "capillary" wedge pressure not the pressure in the pulmonary capillaries.

Authors:  H G Weed
Journal:  Chest       Date:  1991-10       Impact factor: 9.410

Review 5.  Updated clinical classification of pulmonary hypertension.

Authors:  Gérald Simonneau; Ivan M Robbins; Maurice Beghetti; Richard N Channick; Marion Delcroix; Christopher P Denton; C Gregory Elliott; Sean P Gaine; Mark T Gladwin; Zhi-Cheng Jing; Michael J Krowka; David Langleben; Norifumi Nakanishi; Rogério Souza
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

Review 6.  Pulmonary veno-occlusive disease in an adult following bone marrow transplantation. Case report and review of the literature.

Authors:  L M Williams; S Fussell; R W Veith; S Nelson; C M Mason
Journal:  Chest       Date:  1996-05       Impact factor: 9.410

7.  Pulmonary veno-occlusive disease after bone marrow transplantation.

Authors:  X Troussard; J F Bernaudin; C Cordonnier; J Fleury; D Payen; J Briere; J P Vernant
Journal:  Thorax       Date:  1984-12       Impact factor: 9.139

8.  Long-term remission of pulmonary veno-occlusive disease associated with primary Sjögren's syndrome following immunosuppressive therapy.

Authors:  Taio Naniwa; Yutaka Takeda
Journal:  Mod Rheumatol       Date:  2011-03-11       Impact factor: 3.023

9.  Pulmonary venoocclusive disease: CT findings in eight patients.

Authors:  S J Swensen; J H Tashjian; J L Myers; C E Engeler; E F Patz; W D Edwards; W W Douglas
Journal:  AJR Am J Roentgenol       Date:  1996-10       Impact factor: 3.959

Review 10.  Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension.

Authors:  David Montani; Marie-Camille Chaumais; Laurent Savale; Delphine Natali; Laura C Price; Xavier Jaïs; Marc Humbert; Gérald Simonneau; Olivier Sitbon
Journal:  Adv Ther       Date:  2009-09-19       Impact factor: 3.845

View more
  1 in total

1.  Clinical features of canine pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis.

Authors:  Carol R Reinero; L Ari Jutkowitz; Nathan Nelson; Isabelle Masseau; Samuel Jennings; Kurt Williams
Journal:  J Vet Intern Med       Date:  2018-11-29       Impact factor: 3.333

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.